Last $112.82 USD
Change Today +2.73 / 2.48%
Volume 4.9M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GM
As of 5:20 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David W. Gryska MBA

Former Chief Financial Officer and Senior Vice President, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 26 board members in 5 different organizations across 12 different industries.

See Board Relationships
59--

Background*

Mr. David W. Gryska, also known as Dave, MBA has been the Chief Financial Officer and Executive Vice President of Incyte Corporation since October 31, 2014. Mr. Gryska has been Strategic Advisor to the Board at Novogen Limited since March 3, 2014. Mr. Gryska served as an Interim Chief Executive Officer of Myrexis Inc., from August 15, 2012 to December 24, 2012. He served as the Chief Operating Officer of Myrexis, Inc., from May 11, 2012 to December 24, 2012 and served ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Former Director
Former Director
Director
2004-Present
Independent Director and Chairman of Audit Committee
2005-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2010-2014
Former Lead Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2012-2014
Former Director, Chairman of Audit Committee and Member of Compensation Committee
2012-2012
Former Interim Chief Executive Officer, President, Chief Operating Officer and Director
2012-Present
Lead Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Director and Member of Nominating & Governance Committee

Education*

MBA
Golden Gate University
BA
Loyola University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $112.82 USD +2.73

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.